Additionally, the enhanced mitochondrial efficiency seen with this compound could help counteract the cellular energy decline associated with aging, leading to better overall vitality and improved skin elasticity
Primary Benefits: FDA-approved (as Vyleesi) for Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women
Some benefits can include red blood cell formation and nerve cell health
Many patients lose a significant amount of weight while taking this medication
Certified Manufacturing Manufactured in ISO 9001:2015 certified facilities to ensure rigorous, analytical-grade quality control
A licensed provider should review the patients symptoms, medications, medical history, treatment goals, and response before recommending or adjusting a protocol